{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:59:55Z","timestamp":1774306795074,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81403004"],"award-info":[{"award-number":["81403004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81403004"],"award-info":[{"award-number":["81403004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejps.2020.105490","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T19:50:08Z","timestamp":1595706608000},"page":"105490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Enhanced P-glycoprotein expression under high-altitude hypoxia contributes to increased phenytoin levels and reduced clearance in rats"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-7336","authenticated-orcid":false,"given":"Juanhong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105490_bib0001","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.14446","article-title":"Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels","author":"Al Feteisi","year":"2018","journal-title":"J. Neurochem"},{"key":"10.1016\/j.ejps.2020.105490_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2018.06.267","article-title":"Blood-brain barrier (BBB) and the complement landscape","author":"Alexander","year":"2018","journal-title":"Mol. Immunol"},{"key":"10.1016\/j.ejps.2020.105490_bib0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000489806","article-title":"Asiatic acid (AA) sensitizes multidrug-resistant human lung adenocarcinoma A549\/DDP cells to cisplatin (DDP) via downregulation of P-glycoprotein (MDR1) and its targets","volume":"47","author":"Cheng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejps.2020.105490_bib0004","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","article-title":"Potential role of ABC transporters as a detoxification system at the blood-CSF barrier","volume":"56","author":"de Lange","year":"2004","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105490_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2016.04.021","article-title":"Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy","volume":"97","author":"Fang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2020.105490_bib0006","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fct.2017.11.004","article-title":"In vitro screening of dual flavonoid combinations for reversing P-glycoprotein-mediated multidrug resistance: focus on antiepileptic drugs","volume":"111","author":"Ferreira","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2020.105490_bib0007","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-017-2404-1","article-title":"The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study","volume":"132","author":"Jackson","year":"2017","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejps.2020.105490_bib0008","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1359-6446(00)01632-9","article-title":"Efflux transport systems for drugs at the blood\u2013brain barrier and blood\u2013cerebrospinal fluid barrier (Part 1)","volume":"6","author":"Kusuhara","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2020.105490_bib0009","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3892\/etm.2014.2049","article-title":"Changes of pathological and physiological indicators affecting drug metabolism in rats after acute exposure to high altitude","volume":"9","author":"Li","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejps.2020.105490_bib0010","first-page":"19","article-title":"Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: implications of using tet-inducible systems","author":"Luger","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2020.105490_bib0011","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopha.2017.02.092","article-title":"Pharmacokinetic changes of norfloxacin based on expression of MRP2 after acute exposure to high-altitude at 4300\u00a0m","volume":"89","author":"Luo","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejps.2020.105490_bib0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.eplepsyres.2018.06.003","article-title":"Combination of phenobarbital with phenytoin and pregabalin produces synergy in the mouse tonic-clonic seizure model: an isobolographic analysis","volume":"145","author":"Luszczki","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejps.2020.105490_bib0013","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","article-title":"Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2020.105490_bib0014","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1139\/cjpp-2015-0039","article-title":"Serum serotonin reduced the expression of hepatic transporter Mrp2 and P-gp via regulating nuclear receptor CAR in PI-IBS rats","volume":"93","author":"Shao","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105490_bib0015","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1124\/dmd.114.059055","article-title":"Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models","volume":"42","author":"Uchida","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105490_bib0016","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.118.081216","article-title":"Characterization of P-glycoprotein humanized mice generated by chromosome engineering technology: its utility for prediction of drug distribution to the brain in humans","author":"Yamasaki","year":"2018","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.ejps.2020.105490_bib0017","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2018.04.026","article-title":"Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: a potent approach to treat amyotrophic lateral sclerosis","volume":"120","author":"Yang","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105490_bib0018","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/10717544.2018.1469687","article-title":"Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2020.105490_bib0019","first-page":"1616","article-title":"Effect of acute exposure to high-altitude on pharmacokinetics of propranolol and metoprolol in rats","volume":"34","author":"Zhang","year":"2014","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.ejps.2020.105490_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","article-title":"Gut microbiota modulates drug pharmacokinetics","volume":"50","author":"Zhang","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejps.2020.105490_bib0021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1389200219666181019145159","article-title":"Effects of gut microbiota on drug metabolism and guidance for rational drug use under hypoxic conditions at high altitudes","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr. Drug Metab."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720302797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720302797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:54:24Z","timestamp":1760529264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720302797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":21,"alternative-id":["S0928098720302797"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105490","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced P-glycoprotein expression under high-altitude hypoxia contributes to increased phenytoin levels and reduced clearance in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105490"}}